LobbyingCommittee To Protect Health Care lobbying by quarter
Committee To Protect Health Care's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $126K. Its first report covers Q3 2023; the issues it reports most are Health Issues and Medicare/Medicaid.
Committee To Protect Health Care
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $126K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $52K | 2 |
| Q4 2024 | $63K | 2 |
| Q1 2025 | $0 | 2 |
| Q2 2025 | $76K | 2 |
| Q3 2025 | $76K | 2 |
| Q4 2025 | $86K | 2 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$266.5K · 13 reports
- Medicare and Medicaid$96.5K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE13 reports
- HOUSE OF REPRESENTATIVES6 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseCommittee To Protect Health Care | $200K | 12 quarters |
| Waxman Strategies | $193K | 6 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JACKSON RICHARD THEIN | Sen. Jeff Merkley (D-OR), served as Policy Advisor from 2022 - 2023; Legislative Aide from 2021 - 2022; and Legislative Correspondent from 2020 - 2021 | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/14for Q2 | In-house | Under $5,000 |
| 04/28for Q4 2025 | Waxman Strategies | $46K |
| 04/20for Q1 | In-house | $40K |
| 01/20for Q4 2025 | In-house | $40K |
| 01/13for Q4 2025 | Waxman Strategies | $46K |
| 25/10/20for Q3 2025 | In-house | $30K |
| 25/10/14for Q3 2025 | Waxman Strategies | $46K |
| 25/07/18for Q2 2025 | In-house | $30K |
| 25/07/15for Q2 2025 | Waxman Strategies | $46K |
| 25/04/25for Q1 2025 | Waxman Strategies | Under $5,000 |
| 25/04/09for Q1 2025 | In-house | Under $5,000 |
| 25/01/17for Q4 2024 | In-house | $30K |
| 25/01/14for Q4 2024 | Waxman Strategies | $33K |
| 24/10/18for Q3 2024 | In-house | $30K |
| 24/10/17for Q3 2024 | Waxman Strategies | $22K |
| 24/10/16for Q3 2024 | Waxman Strategies | Under $5,000 |
| 24/07/19for Q2 2024 | In-house | Under $5,000 |
| 24/04/09for Q1 2024 | In-house | Under $5,000 |
| 24/01/18for Q4 2023 | In-house | Under $5,000 |
| 23/10/20for Q3 2023 | In-house | Under $5,000 |